Jane Street Group LLC Boosts Stock Holdings in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)

Jane Street Group LLC boosted its position in shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) by 267.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 38,696 shares of the company’s stock after buying an additional 28,176 shares during the period. Jane Street Group LLC owned 19.35% of ProShares UltraShort Nasdaq Biotechnology worth $704,000 at the end of the most recent quarter.

ProShares UltraShort Nasdaq Biotechnology Stock Performance

Shares of ProShares UltraShort Nasdaq Biotechnology stock opened at $19.03 on Monday. The stock’s 50 day simple moving average is $19.58 and its 200-day simple moving average is $17.87. ProShares UltraShort Nasdaq Biotechnology has a 1-year low of $14.05 and a 1-year high of $25.87.

ProShares UltraShort Nasdaq Biotechnology Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, April 1st. Stockholders of record on Wednesday, March 26th were issued a dividend of $0.1325 per share. This represents a $0.53 annualized dividend and a dividend yield of 2.79%. The ex-dividend date of this dividend was Wednesday, March 26th.

ProShares UltraShort Nasdaq Biotechnology Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.